TVRD (STOCKS)
Tvardi Therapeutics, Inc. Common Stock
$3.780000
+0.000000 (+0.00%)
Prev close: $3.780000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Imran Alibhai
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $36.13M
- Employees
- 10
- P/E (TTM)
- -0.38
- P/B (TTM)
- 1.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
4
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.59 | $-1.02 | +0.4297 | +42.14% |
|
Jun 2025 (Q2)
|
$-1.00 | $-0.58 | -0.4167 | -71.44% |
|
Mar 2025 (Q1)
|
$-3.22 | $-0.36 | -2.8630 | -801.96% |
|
Sep 2024 (Q3)
|
$-8.28 | $-9.06 | +0.7777 | +8.59% |